Article thumbnail

EMT and Stem Cell-Like Properties Associated with HIF-2α Are Involved in Arsenite-Induced Transformation of Human Bronchial Epithelial Cells

By Yuan Xu, Yuan Li, Ying Pang, Min Ling, Lu Shen, Xiaojun Yang, Jianping Zhang, Jianwei Zhou, Xinru Wang and Qizhan Liu
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
  2. (2003). Applying the principles of stem-cell biology to cancer.
  3. (2008). Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics.
  4. (2011). Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype.
  5. (2006). Arsenic in the aetiology of cancer.
  6. (2010). Arsenic-specific stem cell selection during malignant transformation.
  7. (2007). Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations.
  8. (2007). Arsenite and insulin exhibit opposing effects on epidermal growth factor receptor and keratinocyte proliferative potential.
  9. (2005). Arsenite maintains germinative state in cultured human epidermal cells.
  10. (2008). Attenuation of DNA damage-induced p53 expression by arsenic: a possible mechanism for arsenic co-carcinogenesis.
  11. (2010). Biologic characteristics of the side population of human small cell lung cancer cell line H446.
  12. (2003). Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation.
  13. (2010). Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition.
  14. (2007). Cano A
  15. (2006). Chromatin immunoprecipitation and microarray-based analysis of protein location.
  16. (2010). Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
  17. (2006). Complex networks orchestrate epithelialmesenchymal transitions.
  18. (2009). E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer.
  19. (2005). Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.
  20. (2002). Effect of four genes (ALDH1, NRF1, JAM and KBL) on proliferation arrest in a non-small cell bronchopulmonary cancer line.
  21. (2011). EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells.
  22. (2010). Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.
  23. (2009). Genomics of lung cancer.
  24. (2006). HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth.
  25. (2009). HIF2alpha maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells.
  26. (2010). Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion.
  27. (2008). Identification and expansion of the tumorigenic lung cancer stem cell population.
  28. (2009). Identification of selective inhibitors of cancer stem cells by high-throughput screening.
  29. (2009). Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.
  30. (2010). mot-2-Mediated cross talk between nuclear factor-B and p53 is involved in arsenite-induced tumorigenesis of human embryo lung fibroblast cells.
  31. (2008). Neoplastic transformation of human small airway epithelial cells induced by arsenic.
  32. (2010). Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
  33. (2008). Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells.
  34. (2009). Oncoprotein BMI-1 induces the malignant transformation of HaCaT cells.
  35. (2005). Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.
  36. (2009). Polycomb group protein Bmi1 is required for growth of RAF driven non-smallcell lung cancer.
  37. (2005). Reciprocal transcriptional regulation of
  38. (2011). Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b.
  39. (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.
  40. (2008). Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.
  41. (2004). Some drinking-water disinfectants and contaminants, including arsenic. Monographs on chloramine, chloral and chloral hydrate, dichloroacetic acid, trichloroacetic acid and 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone.
  42. (2008). Stem cells: The root of prostate cancer?
  43. (2008). The epithelialmesenchymal transition generates cells with properties of stem cells.
  44. (2006). The epithelialmesenchymal transition: new insights in signaling, development, and disease.
  45. (2010). The repressive effect of NFkappaB on p53 by mot-2 is involved in human keratinocyte transformation induced by low levels of arsenite.
  46. (2008). The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha.
  47. (1988). Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.